Abstract:The majority of human skeleton develops through the endochondral pathway, in which cartilage-forming chondrocytes proliferate and enlarge into hypertrophic chondrocytes that eventually undergo apoptosis and are replaced by bone. Although at a terminal differentiation stage, hypertrophic chondrocytes have been implicated as the principal engine of bone growth. Abnormal chondrocyte hypertrophy has been seen in many skeletal dysplasia and osteoarthritis. Meanwhile, as a specific marker of hypertrophic chondrocytes, the type X collagen gene (COL10A1) is also critical for endochondral bone formation, as mutation and altered COL10A1 expression are often accompanied by abnormal chondrocyte hypertrophy in many skeletal diseases. However, how the type X collagen gene is regulated during chondrocyte hypertrophy has not been fully elucidated. We have recently demonstrated that Runx2 interaction with a 150-bp mouse Col10a1 cis-enhancer is required but not sufficient for its hypertrophic chondrocyte-specific reporter expression in transgenic mice, suggesting requirement of additional Col10a1 regulators. In this study, we report in silico sequence analysis of this 150-bp enhancer and identification of its multiple binding factors, including AP1, MEF2, NFAT, Runx1 and TBX5. Using this enhancer as bait, we performed yeast one-hybrid assay and identified multiple candidate Col10a1-interacting genes, including cyclooxygenase 1 (Cox-1) and Cox-2. We have also performed mass spectrometry analysis and detected EF1-alpha, Fus, GdF7 and Runx3 as components of the specific complex formed by the cis-enhancer and nuclear extracts from hypertrophic MCT (mouse chondrocytes immortalized with large T antigen) cells that express Col10a1 abundantly. Notably, some of the candidate genes are differentially expressed in hypertrophic MCT cells and have been associated with chondrocyte hypertrophy and Runx2, an indispensible Col10a1 regulator. Intriguingly, we detected high-level Cox-2 expression in hypertrophic MCT cells. Electrophoretic mobility shift assay and chromatin immunoprecipitation assays confirmed the interaction between Cox-2 and Col10a1 cis-enhancer, supporting its role as a candidate Col10a1 regulator. Together, our data support a Cox-2-containing, Runx2-centered Col10a1 regulatory mechanism, during chondrocyte hypertrophic differentiation.

HOXA10 promotes Gdf5 expression in articular chondrocytes

Expression Profiling and Functional Analysis of Candidate Col10a1 Regulators Identified by the TRAP Program

Inhibition of HOXD11 promotes cartilage degradation and induces osteoarthritis development

A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue-specific expression in hypertrophic cartilage in vitro and in vivo

Impact of Broad Regulatory Regions on Gdf5 Expression and Function in Knee Development and Susceptibility to Osteoarthritis.

Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation

Functional analysis of a first hindlimb positioning enhancer via Gdf11 expression

Foxc1 Establishes Enhancer Accessibility for Craniofacial Cartilage Differentiation.

Growth Differentiation Factor 5 Regulation in Bone Regeneration

Transgenic Mice That Express Cre Recombinasein Hypertrophic Chondrocytes

The G protein-coupled receptor ADGRG6 maintains mouse growth plate homeostasis through IHH Signaling

5' HOXD Genes Differentially Regulate Gene Expression of Synovial Fibroblasts in Hand Joints

A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis

TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages

Doublecortin May Play A Role In Defining Chondrocyte Phenotype

Hoxa5: A Key Player in Development and Disease

Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development

DDX5 inhibits hyaline cartilage fibrosis and degradation in osteoarthritis via alternative splicing and G-quadruplex unwinding

The Role of Gdf5 Regulatory Regions on Development of Hip Morphology and Susceptibility to Osteoarthritis and Dislocation

Growth differentiation factor 5 in cartilage and osteoarthritis: A possible therapeutic candidate

GDF5+ chondroprogenitors derived from human pluripotent stem cells preferentially form permanent chondrocytes